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A Prospective Randomized Comparison of a Single Antibiotic
(Moxalactam) Versus Combination Therapy (Gentamicin and
Clindamycin) in Penetrating Abdominal TVauma
Theodore Fifer, MD,* Farouck N. Obeid, MD,+ H. Mathilda Horst, MD,+
Victor J. Sorensen, MD,^ Larry D. Crots, RPh,* and Brack A. Bivins, MD*

From July 1 to December 31, 1983, 50 consecutive patients undergoing abdominal exploration for
penetrating abdominal trauma from stab and gunshot wounds were prospectively randomized to
receive poslinjury, preoperative antibiotic coverage with moxalactam (2 g intravenously every 12
hours) or a combination of gentamicin (3 to 5 mg/kg/day in three equal doses administered every eighl
hours) and clindamycin (600 mg intravenously every six hours). No intraabdominal abscesses or
wound infections developed, and no direct evidence of toxicity ofthe antibiotic regimens developed in
either group. In the study group, moxalactam therapy was an effective alternative to the combination
antibiotic regimen. The subsequently documented incidence of moxalactam-induced bleeding
episodes precludes its use as a primary preventive antibiotic; however, other less toxic cephalosporins
may demonstrate similar effectiveness. (Henry Ford Hosp MedJ 1988:36:52-5)

Materials and Methods

Patients were randomized according to a predetermined sequence of regimen choices. Special packaging ofthe antibiotics
concealed the identity of the selected regimen to the managing
physicians; once the patient was entered into the study, the antibiotic regimen was revealed to the treating physicians. Antibiotic therapy prior to injury was cause for exclusion from the
study. Group 1 included 25 patients who received gentamicin (3
to 5 mg/kg/day in three equal doses administered every eight
hours) and clindamycin (600 mg intravenously every six hours).
Group 2 included 25 patients who received moxalactam (2 g
intravenously every 12 hours); these patients also received phytonadione (10 mg intramuscularly each week) as part of the protocol. Antibiotics were given according to the randomization
schedule as soon as the decision to explore the abdomen was
made. No other antimicrobials were given during the initial
management period. Treatment was continued a minimum of
three days for patients without injury to hollow viscus. Patients
who were found to have hollow viscus injury at celiotomy received antibiotics for a minimum of five days. Colonic injuries
were managed primarily by exteriorization or colostomy. Patients were routinely explored via midline xiphipubic celiotomy.
Their wounds were closed primarily in the absence of colonic
injury. In the presence of colonic injury, delayed primary
closure was used.
Initial laboratory studies in all patients included complete
blood count with differentials, serum electrolytes, and enzymes

Fifty patients consecutively admitted for penetrating abdominal trauma to the Trauma Surgery Service from July I to December 31, 1983, were entered into a prospective randomized
study. Informed consent regarding the nature of the study was
obtained. The study, consent, and randomization were approved
by the hospital's research review committee.
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ntraabdominal and wound infections are major sources of
morbidity and mortality in patients sustaining penetrating abdominal injury. In the pre-antibiotic era, penetrating abdominal
injury with hollow viscus injury was almost universally fatal.
Today, with modem techniques of transport, resuscitation, and
postoperative management, the early deaths from hemorrhagic
shock have been partly supplanted by late deaths from multiple
system organ failure caused by intraabdominal infection (1-6).
Controversy remains regarding the optimal regimen of perioperative antibiotics, and cost has become an increasingly
important consideration in therapy for these patients. To obtain
the wide spectrum of coverage necessary for abdominal injuries,
multiple dmg regimens traditionally have been recommended
(2,7,8). Treatment with one antibiotic has been found to be effective in comparison to multidrug regimens (9-15). Agents recommended are usually of the newer generation cephalosporin
type due to their wide spectra including both anaerobes and
aerobes (16-18). Some studies have found multiple drug regimens to be superior to treatment with one antibiotic therapy of
cefamandole or cefoxitin but not of moxalactam (19,20).
In an effort to further clarify the role of single antibiotic therapy in abdominal trauma, a moxalactam regimen was prospectively compared to the more traditional two-drug combination
including an aminoglycoside.

I
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Table 1
Study Population Demographics

Table 2
Patterns of Injury

Group 1
Gentamicin/Clindamycin

Group 2
Moxalactam

27
17-57

27,1
18-66

23
2

23
2

10,4
3-28
261

9,5
3-21
238

Age (years)
Mean
Range
Gender
Male
Female
Hospitalization (days)
Mean
Range
Total

Number of patients
Hollow viscus injury
Colon injury
Gunshot wound
Stab wound
Solid organ injury
(liver, spleen, pancreas.
kidney, ovary)
"Negative" laparototnies

Group I
Gentamicin/Clindamycin

Group 2
Moxalactam

25
12
4
20
5

25
1 1
2
15
10

7
5

15
7

consisting of calcium, phosphoms, magnesium, SGOT, SGPT,
lactic dehydrogenase alkaline phosphatase, creatinine phosphokinase, creatinine, total bilimbin, total protein, cholesterol,
triglyceride, BUN, uric acid, and glucose. Urinalysis was obtained. Coagulation parameters, prothrombin time, and partial
thromboplastin time with platelet count were obtained. Cultures
of intraperitoneal fluid, blood, and wound surface were obtained
aerobically and anaerobically within four hours of antibiotic administration. Organisms isolated in such cultures were tested
for sensitivity to the antibiotics. In vitro susceptibility to moxalactam was evaluated by determination of minimum inhibitory
concentration. The Kirby-Bauer disk diffusion method was
used to test sensitivity of isolated organisms to gentamicin
and clindamycin.
Inpatient follow-up included daily physical examinations, vital sign determinations every eight hours, and selected laboratory studies during the study period and three times weekly after
the study period until discharge. Postdischarge follow-up was
continued for at least two weeks. Failure of antibiotic therapy
was defined as an oral temperature greater than 38°C on two
occasions more than six hours apart, a WBC count greater
than 20,000/pL, wound infection requiring drainage, intraabdominal abscess formation, or positive blood cultures.

wound cultures. Four patients receiving moxalactam had
positive peritoneal cultures as opposed to three patients in the
gentamicin/clindamycin group. One patient receiving moxalactam after multiple gunshot wounds to the chest, abdomen, and
extremities had a positive wound culture for an enterococcus
and developed a postoperative fever. The fever, however, resolved with intensive pulmonary toilet, and no obvious focus of
enterococcal infection was identified.
After study antibiotics were discontinued, two patients
receiving moxalactam had positive wound cultures for an
enterococcus and Staphylococcus epidermidis but wound infection requiring drainage did not develop. Another patient receiving gentamicin and clindamycin had a positive wound culture
for Pseudomonas aeruginosa and Staphylococcus epidermidis
but wound infection requiring intervention did not develop.
No overt symptoms of toxicity developed in any patient. One
patient receiving moxalactam had a transient elevation of semm
creatinine (> 2.0 mg/dL), which resolved within 48 hours without specific change in therapy. Abnormal coagulation parameters, which also resolved without specific intervention, were
observed in two patients receiving gentamicin and clindamycin
and one patient receiving moxalactam. No clinical episodes of
bleeding or ototoxicity were noted.

Results

Discussion

Population demographics are summarized in Table I. The 25
patients who received gentamicin and clindamycin (group 1)
ranged in age from 17 to 57 years (mean 27 years). The 25 patients who received moxalactam (group 2) ranged in age from 18
to 62 years (mean 27.1 years). Both groups contained 23 men
and two women. Patterns of injury are summarized in Table 2.
Twelve of the patients randomized to the gentamicin/clindamycin group had hollow viscus injury at celiotomy, with four
ofthe patients sustaining injuries to the colon. Eleven ofthe patients receiving moxalactam had hollow viscus injury, with two
of the patients sustaining injuries to the colon. Of the patients
randomized to the gentamicin/clindamycin group, 20 sustained
gunshot wounds and five had stab wounds. Of the patients in
the moxalactam group, 15 sustained gunshot wounds and ten
had stab wounds. No stab wounds resulted in colonic injury in
either group.
No patients in this study developed an infection requiring surgical intervention. Several patients had positive peritoneal or

Antimicrobials have four clinical applications: 1) primary
therapy, as in the treatment of pneumonia; 2) prophylaxis, as in
coverage for an elective operation (where antibiotics are given
prior to contamination); 3) preventive, as when contamination
has already occurred; and 4) adjunctive, as in the management
of an abscess where drainage is the primary therapy. Antibiotic
treatment of the traumatized patient begins after injury (and
therefore after contamination) and must be considered preventive. The therapy should be directed against pathogens most
likely to cause infection, such as the microflora residing in the
gut of the acutely traumatized patient. While the normal stomach and proximal small bowel contain relatively few bacteria in
most patients, the distal small bowel and colon contain a high
concentration (up to 10" organisms per gram) (21,22) of aerobic
and anaerobic species including Bacillus fragilis, aerobic enterococci, Pseudomonas species, and anaerobic Streptococcus
and Fusobacterium. In patients with postsurgical intraabdominal abscesses, mixed flora of anaerobes and aerobes are
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recovered five times more frequently than either aerobes or anaerobes alone (21). Theories of microbial synergism abound (2).
When risk factors of penetrating abdominal trauma were examined in 338 patients, colon injury and wounding by gunshot
emerged as significant risk factors for trauma-related infections
(5). In an experimental model of colonic perforation, 29 different regimens were compared for incidence of fatal peritonitis and abscess formarion (11). The most effective regimens
were those which combined agents effective against coliforms
(aerobes) and Bacillus fragilis (11,13).
In a study of 295 patients sustaining penetrating abdominal
trauma, those who received antibiotics preoperatively had a
significantiy lower incidence of wound infection, abscess, and
sepsis (23). The question of how long to continue therapy
postoperatively has not been resolved. In a prospective randomized study of 82 patients requiring celiotomy for penetrating
abdominal trauma, a 12-hour postoperative course of antibiotics
was comparable to a five-day course in the prevention of
postoperative infection (4). Statisticafly significant differences
of infection rate were not found between preoperative only and
preoperative plus 24-hour antibiotic regimens in a series of 360
patients sustaining abdominal trauma (14).
Although antibiotics reduce the risk of infection in abdominal
trauma, the choice of antibiotics remains controversial. Combination therapy with an aminoglycoside has been popular, even
though aminoglycoside antibiotics tend to produce nephrotoxicity and ototoxicity. Of parricular significance is that the
ototoxic damage is often permanent due to destruction of
cochlear hair cells. The new cephalosporins have antimicrobial
spectra which compare favorably to that of combination therapy
and may be less toxic (16,17,24).
Moxalactam has been noted to cause blood clotting derangements. The mechanisms are: 1) an acute interference with
vitamin K metabolism superimposed on a chronic vitamin K deficiency, and 2) platelet dysfunction. Supplemental vitamin K
reverses humoral clotting derangements (25). The frequency of
moxalactam-induced bleeding events, most ofwhich are serious, has been reported to be 2.5% for those receiving moxalactam for four or more days (24). Because of this incidence,
use of moxalactam as a primary preventive antibiotic has been
abandoned.
In our series, wound infection requiring surgical intervention
did not develop even though positive cultures of the wounds
were obtained. Culture of an organism from a wound does not
represent infection but does indicate the presence of that organism in sufficient numbers to produce colony-forming units (26).
The probability of infection in a wound is directly proportional
to inoculum size and pathogen virulence and inversely proportional to local and systemic defenses (27). The results ofthis
study provide support for previous reports indicating that broad
spectrum cephalosporin therapy is clinically equivalent to combination therapy in abdominal trauma (9,11,13,14).
The populations included herein are insufficient to eliminate
the possible existence of a type 2 error. Populations sizable
enough to determine the exact difference in rates of postpenetrating abdominal trauma infections between the two regimens would be difficult to achieve given the overall low rate of
infection with adequate surgical therapy. One obstacle to routine
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use of the newer cephalosporins has been the perceived high cost
of these antibiotics. In a previous study, the total cost of antibiotic therapy for patients with penetrating abdominal trauma was
approximately $125 higher per patient for the combination of
gentamicin and clindamycin versus single agent therapy of moxalactam. This study considered cost per dose, personnel time,
supply cost, and the cost of laboratory monitoring (28).
In our study, 2 g of moxalactam given intravenously every 12
hours was found to be of comparable efficacy to a gentamicin/
clindamycin combination. Unfortunately, coagulopathy associated with use of moxalactam is serious enough to preclude its
use in a preventive setting. Nevertheless, single antibiotic regimens with less toxic third generation cephalosporins appear to
be a fruitful area for future research.
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